Enanta Pharmaceuticals Inc (Enanta) is a clinical-stage biotechnology company that develops small molecule drugs for viral infections. The company’s pipeline includes glecaprevir, EDP-514, EDP-938, EDP-323, EDP-235, EDP-305, EDP - 297.h Its pipeline candidates treat hepatitis C virus (HCV), Hepatitis B virus (HBV), respiratory syncytial virus (RSV), COVID-19 and non-alcoholic steatohepatitis (NASH). Its brands include Mavyret and Vieira pak. The company works in partnership with the National Institute of Allergy and Infectious Diseases, AbbVie Inc, Novartis, Shionogi Inc to discover two protease inhibitor compounds. Enanta is headquartered in Watertown, Massachusetts, the US.
Enanta Pharmaceuticals Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Glecaprevir - Hepatitis C Virus (HCV) | MAVYRET |
EDP-514 - Hepatitis B virus (HBV) | VIEKIRA PAK |
EDP-938- Respiratory Syncytial Virus (RSV) | |
XYZ | |
XYZ | |
XYZ |
Competitor Comparison
Key Parameters | Enanta Pharmaceuticals Inc | DMK Pharmaceuticals Corp | Axim Biotechnologies Inc | Eledon Pharmaceuticals Inc | Global Life Sciences Solutions USA LLC |
---|---|---|---|---|---|
Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
City | Watertown | San Diego | San Diego | Irvine | Marlborough |
State/Province | Massachusetts | California | California | California | Massachusetts |
No. of Employees | 145 | 11 | 6 | 20 | - |
Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Bruce L.A. Carter | Chairman | Executive Board | 2015 | 79 |
Jay R. Luly | Director; President; Chief Executive Officer | Executive Board | 2003 | 66 |
Paul J. Mellett | Chief Financial Officer; Senior Vice President - Finance and Administration | Senior Management | 2003 | 67 |
Scott T. Rottinghaus | Senior Vice President; Chief Medical Officer | Senior Management | 2022 | 49 |
Yat Sun Or, Ph.D. | Senior Vice President - Research and Development; Chief Scientific Officer | Senior Management | 1999 | 71 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer